Newsletter
GOP lawmaker files federal cannabis rescheduling bill (Newsletter: August 14, 2025)
IN gov: Fed marijuana reform could boost state legalization; DEA “drug slang” quiz; Study: Medical cannabis for pain; SXSW psychedelics panels
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Rep. Greg Steube (R-FL) filed the Marijuana 1-to-3 Act in Congress, which would move cannabis to Schedule III as President Donald Trump separately considers an administrative rescheduling process.
The Drug Enforcement Administration launched a “drug slang” quiz to test people’s knowledge of marijuana, meth, fentanyl, MDMA and cocaine terminology.
Indiana Gov. Mike Braun (R) said federal marijuana rescheduling under the Trump administration “probably adds a little more fuel to the fire in terms of the speed with which” his state could legalize cannabis.
- Meanwhile, U.S. Sen. Jim Banks (R-IN) said, “I hope Indiana is never a state that legalizes marijuana, by the way.”
South by Southwest (SXSW) is accepting public votes on proposed cannabis and psychedelics-focused panels for the 2026 festival—with discussions on the need for marijuana clemency, putting cannabis products in convenience stores, the therapeutic potential of ibogaine to treat head trauma in athletes and even a psychedelic “puppet show.”
A new study shows that “medical cannabis has genuine therapeutic effects for pain management”—and that terpenoids are “key predictors of treatment response” as part of an entourage effect, while “THC and CBD provide limited predictive value” for relief.
- “Pain relief can be predicted from cannabis chemical profiles that are unknown to patients, providing evidence for compound-specific therapeutic effects” which “emerge from specific combinations of compounds working in concert, rather than from any single component.”
A new study funded by the Department of Justice’s National Institute of Justice found “little to no support” for claims that Oregon’s now-repealed drug decriminalization law led to increased overdose deaths and crime.
/ FEDERAL
A federal judge rejected the Department of Homeland Security’s motion to dismiss a lawsuit filed by a Canadian cannabis harvesting equipment company CEO.
Drug Enforcement Administration Administrator Terrance Cole discussed his new role overseeing the Washington, D.C. Metropolitan Police Department.
Sen. Rand Paul (R-KY) tweeted, “I’m fighting for commonsense hemp regulation for Kentucky innovators like @hempwood. We make alcohol from corn, but we don’t regulate how much alcohol is in the corn. You regulate what’s being consumed. Washington’s approach to hemp should be similar.”
/ STATES
Florida’s attorney general is moving to ban the kratom-related compound 7-OH.
A former Kansas representative authored a post about his support for marijuana reform.
Missouri regulators are accepting applications for a marijuana revenue-funded grant program on substance use disorder issues.
California regulators sent an update on marijuana-related actions over the past quarter.
Rhode Island regulators revoked a marijuana cultivation license following an arrest.
The Utah Medical Cannabis Policy Advisory Board considered presentations on medical cannabis pricing and the decriminalization of flower combustion.
New York regulators posted an FAQ about the pausing of a deadline to implement marijuana seed-to-sale tracking.
New Jersey regulators published data on marijuana business licensing demographics.
Maryland regulators fined a marijuana business for allegedly violating advertising rules by indirectly targeting people under the age of 21.
Oregon regulators sent a newsletter with updates on the psilocybin services program.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The Colorado Springs, Colorado City Council passed a resolution recommending the mayor allocate marijuana revenue to PTSD recovery programs.
/ INTERNATIONAL
Caye Caulker, Belize activists collected enough signatures to put a marijuana legalization referendum on the ballot.
/ SCIENCE & HEALTH
A study found that “open-label CBD treatment was associated with sustained seizure reduction through 144 weeks, with a consistent safety profile in patients with treatment-resistant focal epilepsies, regardless of epilepsy type.”
A study said it is the first “to definitively link an infection to a pathogen in medical cannabis used by the patient.”
/ ADVOCACY, OPINION & ANALYSIS
A poll of likely Texas Republican primary voters found that they support a ban on hemp-derived THC products, 62 percent to 30 percent.
The National Safety Council collaborated on research protocol to study the impact of marijuana, alcohol and fatigue on alertness and impairment.
/ BUSINESS
Organigram Global Inc. reported quarterly net revenue of C$70.8 million and a net loss of C$6.3 million.
Charlotte’s Web Holdings, Inc. reported quarterly revenue of $12.8 million and a net loss of $6.3 million.
Grown Rogue International Inc. reported quarterly revenue of $5.6 million.
High Tide Inc. has a new vice president of digital and ecommerce.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis/Side Pocket Images.
